QA: Bioxytran INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2026_Bioxytran_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 513,465
1 IntangibleAssetsNetIncludingGoodwill 145,087
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 3,249,894
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 696,936
9 ResearchAndDevelopmentExpense 387,869
10 remainder_Expenses 757,204
11 remainder_Revenues 0
12 remainder_NetIncome -285,188
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 658,552
1 Liabilities 3,249,894
2 Expenses 1,842,009
3 Revenues 0
4 StockholdersEquity -2,591,342
5 NetIncome -2,127,197
6 ComprehensiveNetIncome -2,127,197
7 BaseVar 3,017,822
8 EconomicCapitalRatiobeforeLimitedLiability -3.98
9 EconomicCapitalRatio 0.397

Edgar->Model Mapping

Feature Distribution

Change over Time